Mild to moderate idiopathic pulmonary fibrosis (IPF)

Active Ingredient: Pirfenidone

Indication for Pirfenidone

Population group: only adults (18 years old or older)

Pirfenidone is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).

For this indication, competent medicine agencies globally authorize below treatments:

801-2,403 mg in 3 divided doses daily

Route of admnistration

Oral

Defined daily dose

801 - 2,403 mg

Dosage regimen

From 267 To 801 mg 3 time(s) per day every day

Detailed description

Upon initiating treatment, the dose should be titrated to the recommended daily dose of nine capsules per day over a 14-day period as follows:

  • Days 1 to 7: 267 mg, three times a day (801 mg/day)
  • Days 8 to 14: 534 mg, three times a day (1602 mg/day)
  • Day 15 onward: 801 mg, three times a day (2403 mg/day)

The recommended maintenance daily dose of Esbriet is three 267 mg capsules three times a day with food for a total of 2,403 mg/day.

Doses above 2403 mg/day are not recommended for any patient.

Patients who miss 14 consecutive days or more of Esbriet treatment should re-initiate therapy by undergoing the initial 2-week titration regimen up to the recommended daily dose.

For treatment interruption of less than 14 consecutive days, the dose can be resumed at the previous recommended daily dose without titration.

Dosage considerations

It should be taken with food to reduce the possibility of nausea and dizziness.

Active ingredient

Pirfenidone

Pirfenidone attenuates fibroblast proliferation, production of fibrosis-associated proteins and cytokines, and the increased biosynthesis and accumulation of extracellular matrix in response to cytokine growth factors. Pirfenidone is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).

Read more about Pirfenidone

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner

Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.